Surveillance for hepatocellular carcinoma in cirrhosis: is it cost-effective?
Authors:
- F FarinatiFFF Farinati
- S GianniSGS Gianni
- 1 February 2001
- journal article
- conference paper
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 10 (1) , 111-115
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Screening for Hepatocellular Carcinoma in Patients With Advanced CirrhosisAmerican Journal of Gastroenterology, 1999
- High Prevalence of Multinodular Hepatocellular Carcinoma in Patients With Cirrhosis Attributable to Multiple Risk FactorsHepatology, 1999
- Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosisCancer, 1999
- Screening for hepatocellular carcinomaHepatology, 1998
- Epidemiological characteristics and risk factors of hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 1997
- Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patientsGastroenterology, 1995
- Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoproteinJournal of Hepatology, 1994
- Primary treatment of hepatocellular carcinoma by arterial chemoembolizationThe American Journal of Surgery, 1992
- Hepatocellular Carcinoma in Italian Patients with CirrhosisNew England Journal of Medicine, 1991
- Unresectable hepatocellular carcinoma: a prospective controlled trial with tamoxifenJournal of Hepatology, 1990